Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
China · Delayed Price · Currency is CNY 5.36
-0.24 (-4.29%)
Nov 13, 2026, 3:00 PM CST
SHA:603669 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 150.54 | 155.51 | 254.09 | 343.42 | 575.76 | 986.94 |
Trading Asset Securities | 6.74 | 13.32 | 31.22 | 390.59 | 389.51 | 579.13 |
Cash & Short-Term Investments | 157.28 | 168.83 | 285.31 | 734.01 | 965.28 | 1,566 |
Cash Growth | -17.79% | -40.83% | -61.13% | -23.96% | -38.36% | -10.36% |
Accounts Receivable | 331.43 | 256.22 | 243.2 | 65.6 | 92.21 | 124.89 |
Other Receivables | 8.94 | 2.4 | 4.69 | 2.18 | 3.53 | 7.71 |
Receivables | 340.37 | 258.61 | 247.89 | 67.78 | 95.74 | 132.61 |
Inventory | 71.14 | 84.03 | 27.88 | 56.77 | 49.14 | 51.67 |
Other Current Assets | 19.51 | 13.9 | 25.53 | 22.97 | 21.89 | 37.95 |
Total Current Assets | 588.3 | 525.38 | 586.61 | 881.53 | 1,132 | 1,788 |
Property, Plant & Equipment | 388.98 | 405.17 | 469.67 | 505.35 | 496.32 | 484.53 |
Long-Term Investments | 64.1 | 64.46 | 75.67 | 100.87 | 77.8 | 66.67 |
Goodwill | - | - | - | - | - | 2.03 |
Other Intangible Assets | 88.63 | 93.61 | 100.9 | 108.44 | 115.79 | 124.1 |
Long-Term Deferred Tax Assets | - | - | - | 2.2 | 0.21 | 6.83 |
Long-Term Deferred Charges | 9.37 | 11.42 | 14.23 | 17.15 | 20.1 | 23.92 |
Other Long-Term Assets | 8.34 | 6.73 | 8.25 | 9.02 | 13.22 | 18 |
Total Assets | 1,148 | 1,107 | 1,255 | 1,625 | 1,855 | 2,514 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 141.65 | 108.57 | 89.13 | 85.5 | 49.26 | 48.53 |
Accrued Expenses | 2.11 | 13.68 | 22.06 | 11.95 | 14.6 | 25.25 |
Short-Term Debt | 15.01 | 15.01 | - | 117.41 | 205.24 | 460.29 |
Current Portion of Long-Term Debt | 292.49 | 272.6 | 0.42 | 0.38 | - | 85.06 |
Current Portion of Leases | - | 1.94 | 1.77 | 2.64 | 1.14 | 3.19 |
Current Income Taxes Payable | 3.76 | 0.11 | 0.03 | 0.31 | 0.02 | 1.28 |
Current Unearned Revenue | 10.11 | 11.77 | 6.88 | 10.48 | 8.84 | 6.61 |
Other Current Liabilities | 5.86 | 54.9 | 99.03 | 14.44 | 23.33 | 18.64 |
Total Current Liabilities | 470.99 | 478.58 | 219.31 | 243.11 | 302.42 | 648.85 |
Long-Term Debt | 17 | - | 257.99 | 439.34 | 412.52 | 385.91 |
Long-Term Leases | 2.13 | 2.13 | 4.07 | 5.84 | 1.07 | 14.77 |
Long-Term Unearned Revenue | 4.3 | 4.47 | 2.41 | 2.8 | 4.09 | 5.81 |
Long-Term Deferred Tax Liabilities | 0.97 | 1.32 | 1.78 | 2.42 | 0.74 | 0.19 |
Total Liabilities | 495.38 | 486.5 | 485.57 | 693.52 | 720.84 | 1,056 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 712.36 | 721.25 | 721.24 | 721.24 | 721.24 | 721.23 |
Additional Paid-In Capital | 253.56 | 304.4 | 262.65 | 255.64 | 255.63 | 255.54 |
Retained Earnings | -323.74 | -355.56 | -162.32 | -31.56 | 119.94 | 387.95 |
Treasury Stock | -50.02 | -110.02 | -110.02 | -108.37 | -56.26 | - |
Comprehensive Income & Other | 60.17 | 60.21 | 58.21 | 94.09 | 94.09 | 94.11 |
Shareholders' Equity | 652.33 | 620.28 | 769.76 | 931.04 | 1,135 | 1,459 |
Total Liabilities & Equity | 1,148 | 1,107 | 1,255 | 1,625 | 1,855 | 2,514 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 326.63 | 291.68 | 264.26 | 565.61 | 619.97 | 949.22 |
Net Cash (Debt) | -169.35 | -122.85 | 21.05 | 168.4 | 345.3 | 616.84 |
Net Cash Growth | - | - | -87.50% | -51.23% | -44.02% | -28.25% |
Net Cash Per Share | -0.24 | -0.17 | 0.03 | 0.23 | 0.48 | 0.86 |
Filing Date Shares Outstanding | 712.46 | 703.54 | 703.54 | 703.83 | 721.24 | 721.23 |
Total Common Shares Outstanding | 712.46 | 703.54 | 703.54 | 703.83 | 721.24 | 721.23 |
Working Capital | 117.31 | 46.8 | 367.3 | 638.42 | 829.62 | 1,139 |
Book Value Per Share | 0.92 | 0.88 | 1.09 | 1.32 | 1.57 | 2.02 |
Tangible Book Value | 563.71 | 526.67 | 668.86 | 822.61 | 1,019 | 1,333 |
Tangible Book Value Per Share | 0.79 | 0.75 | 0.95 | 1.17 | 1.41 | 1.85 |
Buildings | - | 366.87 | 374.09 | 378.47 | 369.78 | 316.92 |
Machinery | - | 142.62 | 162.03 | 187.09 | 191.33 | 197.49 |
Construction In Progress | - | 190.83 | 228.22 | 220.06 | 190.18 | 187.96 |